2018
DOI: 10.5216/ree.v20.52232
|View full text |Cite
|
Sign up to set email alerts
|

Sequenciamento de infusão de antineoplásicos: contribuições para a prática de enfermagem oncológica baseada em evidência

Abstract: Este estudo objetivou identificar as evidências científicas disponíveis acerca das interações medicamentosas entre antineoplásicos decorrentes da ordem de infusão para, então, descrever a melhor sequência de aplicação e discutir sua aplicabilidade na Sistematização da Assistência de Enfermagem (SAE). Revisão integrativa da literatura operacionalizada em 2018 nas bases MEDLINE, LILACS, CINAHL e BVS, a partir dos termos Neoplasms, Drug Therapy, Drug Interactions, Chemotherapy e Sequence Administration. Foram ana… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 67 publications
(102 reference statements)
0
1
0
Order By: Relevance
“…The optimal combinations were explored, along with the most appropriate administration schedules and the potential underlying molecular mechanisms of action. The combination strategies used in this study are clinically used to test the anticancer drug efficacy [ 21 23 ]. We sought to use those clinically applied strategies to test the combination of a clinically used anticancer drug, Sora and PPCs in searching for a novel, more potent combination.…”
Section: Discussionmentioning
confidence: 99%
“…The optimal combinations were explored, along with the most appropriate administration schedules and the potential underlying molecular mechanisms of action. The combination strategies used in this study are clinically used to test the anticancer drug efficacy [ 21 23 ]. We sought to use those clinically applied strategies to test the combination of a clinically used anticancer drug, Sora and PPCs in searching for a novel, more potent combination.…”
Section: Discussionmentioning
confidence: 99%